氯乙酰氯

Search documents
凯盛新材: 2023年山东凯盛新材料股份有限公司向不特定对象发行可转换公司债券2025年跟踪评级报告
Zheng Quan Zhi Xing· 2025-06-13 11:50
Core Viewpoint - The company maintains a stable credit rating outlook, reflecting its strong position in the chlorosulfonic acid market and its advantages in the industrial chain, technology, and scale [2][6][19]. Company Overview - The company, Shandong Kaisheng New Materials Co., Ltd., is a leading producer of chlorosulfonic acid and aramid polymer monomers, with a significant market share in both domestic and global markets [2][19]. - The company has a registered capital of 421 million yuan, with its major shareholder being Huabang Life Health Co., Ltd., which holds 44.51% of the shares [9]. Financial Performance - The company's total assets as of the end of 2024 were 24.11 billion yuan, with total liabilities primarily consisting of convertible bonds [3][4]. - The operating income for the company was 2.69 billion yuan, with a net profit of 0.31 billion yuan, reflecting a decline in profitability due to various market pressures [3][4][5]. - The company’s main product, chlorosulfonic acid, experienced a price drop, leading to a significant reduction in profit margins [5][11]. Market Environment - The chlorosulfonic acid market saw a decline in demand, with consumption dropping by 10.66% year-on-year, resulting in a market size of 5.23 billion yuan [11][12]. - The company faces increased competition and fluctuating raw material prices, which have pressured profit margins across its product lines [5][11][15]. Production and Capacity - The company has a chlorosulfonic acid production capacity of approximately 59.50 million tons per year, with a utilization rate of 59.88% [12][13]. - The company is also expanding its production capacity for aramid polymer monomers, with a new project expected to begin trial production in the second half of 2025 [5][19]. Research and Development - The company invested 0.54 billion yuan in research and development in 2024, focusing on high-end chemical products and polymer materials [19]. - The company holds 136 valid patents, including 93 invention patents, indicating a strong commitment to innovation and technology [19]. Risk Factors - The company faces environmental and safety risks associated with its chemical manufacturing processes, particularly concerning waste management and compliance with stricter regulations [5][19]. - The company is also under pressure from rising capital expenditures related to new projects and the need to manage production capacity effectively [5][19].